Obesity as a potential confounder of clozapine-induced myocarditis in the Hunter region of Australia

Schizophr Res. 2024 May:267:42-43. doi: 10.1016/j.schres.2024.03.004. Epub 2024 Mar 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents* / adverse effects
  • Australia
  • Clozapine* / adverse effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocarditis* / chemically induced
  • Obesity* / chemically induced
  • Schizophrenia* / drug therapy